Kidney Cancer Diagnostics Market Crucial Study of Industry, Top Players and Forecasts till 2022
Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes. This cancer originates in two principal locations of the kidney – the renal pelvis and the renal tubule.
Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=56
Targeted Systemic Therapies for Metastatic Kidney Cancer are Providing Significant Benefits to Survival and Progression
Over the past few years, the diagnosis and management of kidney cancer, or, renal cell carcinoma (RCC), have undergone tremendous transformations. A number of discoveries, studies, and trails are being taken in renal mass biopsy, minimally-invasive thermal ablation, and active surveillance, owing to the surge in diagnosis rate of small renal masses, usually in patients with high morbidity risks related to operative treatment. In addition, targeted systemic therapies associated with metastatic kidney cancer have replaced cytokine-based treatment, providing significant benefits to survival and progression. Recent trails and reviews have cemented the partial nephrectomy’s role as the standard diagnosis-based surgical management option for majority of low-stage masses, and roles of adrenalectomy and lymphadenectomy pertaining to nephrectomy. These incidences are estimated to augment growth of the global kidney cancer diagnostics market.
9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market
- Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
- Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.
- Cancer research institutes will register the fastest expansion in the market during the forecast period.
- Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
- Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.
- Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
- North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
- Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
- Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.
North America to Remain the Largest Market for Kidney Cancer Diagnostics
In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.
Competition Tracking
Myriad Genetics Inc, NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories are observed as key players in the global market for kidney cancer diagnostics.
Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=56
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: [email protected]
Web: https://www.factmr.com/